Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

por Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M
Publicado 2008

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

por Joosten, S.E.P., Retèl, V.P., Coupé, V.M.H., van den Heuvel, M.M., van Harten, W.H.
Publicado 2016

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

por Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M
Publicado 2010

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

por Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Publicado 2012

Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis

por van den Boorn, H. G., Engelhardt, E. G., van Kleef, J., Sprangers, M. A. G., van Oijen, M. G. H., Abu-Hanna, A., Zwinderman, A. H., Coupé, V. M. H., van Laarhoven, H. W. M.
Publicado 2018

Decision support systems for incurable non-small cell lung cancer: a systematic review

por Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., Jansma, E. P., De Vet, H. C. W., Coupé, V. M. H.
Publicado 2017

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing

por Vessies, D. C. L., Greuter, M. J. E., van Rooijen, K. L., Linders, T. C., Lanfermeijer, M., Ramkisoensing, K. L., Meijer, G. A., Koopman, M., Coupé, V. M. H., Vink, G. R., Fijneman, R. J. A., van den Broek, D.
Publicado 2020

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyper...

por Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupé, V. M. H., Beliën, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., te Velde, E. A.
Publicado 2016

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design

por Wisse, P. H. A., de Klaver, W., van Wifferen, F., Meiqari, L., Bierkens, M., Greuter, M. J. E., Carvalho, B., van Leerdam, M. E., Spaander, M. C. W., Dekker, E., Coupé, V. M. H., de Wit, M., Meijer, G. A.
Publicado 2022

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis

por Goos, J A C M, Coupe, V M H, Diosdado, B, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Carvalho, B, van den Tol, M P, Verheul, H M W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado 2013

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

por Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado 2014

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

por de Cuba, E. M. V., de Hingh, I. H. J. T., Sluiter, N. R., Kwakman, R., Coupé, V. M. H., Beliën, J. A. M., Verwaal, V. J., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Bonjer, H. J., Meijer, G. A., te Velde, E. A.
Publicado 2016

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

por Bosch, L.J.W., Melotte, V., Mongera, S., Daenen, K.L.J., Coupé, V.M.H., van Turenhout, S.T., Stoop, E.M., de Wijkerslooth, T.R., Mulder, C.J.J., Rausch, C., Kuipers, E.J., Dekker, E., Domanico, M.J., Lidgard, G.P., Berger, B.M., van Engeland, M., Carvalho, B., Meijer, G.A.
Publicado 2019

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

por Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R., Koopman, M.
Publicado 2020

Cost-utility of an eHealth application ‘Oncokompas’ that supports cancer survivors in self-management: results of a randomised controlled trial

por van der Hout, A., Jansen, F., van Uden-Kraan, C. F., Coupé, V. M., Holtmaat, K., Nieuwenhuijzen, G. A., Hardillo, J. A., de Jong, R. J. Baatenburg, Tiren-Verbeet, N. L., Sommeijer, D. W., de Heer, K., Schaar, C. G., Sedee, R. J. E., Bosscha, K., van den Brekel, M. W. M., Petersen, J. F., Westerman, M., Honings, J., Takes, R. P., Houtenbos, I., van den Broek, W. T., de Bree, R., Jansen, P., Eerenstein, S. E. J., Leemans, C. R., Zijlstra, J. M., Cuijpers, P., van de Poll-Franse, L. V., Verdonck-de Leeuw, I. M.
Publicado 2020